Cargando…
Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-onset AOSD have not been reported. To clarify the clinical feat...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734186/ https://www.ncbi.nlm.nih.gov/pubmed/36494453 http://dx.doi.org/10.1038/s41598-022-25514-6 |
_version_ | 1784846536050475008 |
---|---|
author | Yagishita, Mizuki Tsuboi, Hiroto Kuroda, Yuki Sawabe, Tomonori Kawashima, Akira Kawashima, Fumina Uematsu, Nana Sato, Ryota Nishiyama, Taihei Terasaki, Mayu Toko, Hirofumi Honda, Fumika Ohyama, Ayako Abe, Saori Kitada, Ayako Miki, Haruka Hagiwara, Shinya Kondo, Yuya Sumida, Takayuki Matsumoto, Isao |
author_facet | Yagishita, Mizuki Tsuboi, Hiroto Kuroda, Yuki Sawabe, Tomonori Kawashima, Akira Kawashima, Fumina Uematsu, Nana Sato, Ryota Nishiyama, Taihei Terasaki, Mayu Toko, Hirofumi Honda, Fumika Ohyama, Ayako Abe, Saori Kitada, Ayako Miki, Haruka Hagiwara, Shinya Kondo, Yuya Sumida, Takayuki Matsumoto, Isao |
author_sort | Yagishita, Mizuki |
collection | PubMed |
description | Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-onset AOSD have not been reported. To clarify the clinical features and cytokine profiles of elderly-onset AOSD, we examined patients with AOSD who developed the disease between January 2006 and September 2021. We divided the patients into the young and middle-aged-onset group (aged < 65 years) and the elderly-onset group (aged ≥ 65 years) and compared the groups in terms of patient characteristics, clinical symptoms, laboratory findings including serum interleukin (IL)-6 and IL-18, treatment, and prognosis. A total of 48 patients were examined (10 in the elderly-onset group). In the elderly-onset group, atypical rash was significantly more frequent, typical rash and splenomegaly were significantly less frequent, white blood cell count and neutrophil ratio were significantly higher and serum IL-6 levels were significantly lower. Serum IL-6 showed a significantly negative correlation with age at onset. Treatment and relapse were comparable between the 2 groups, whereas infections were significantly more frequent in the elderly-onset group. The clinical features and cytokine profiles of elderly-onset AOSD might differ from those of young and middle-aged-onset AOSD. |
format | Online Article Text |
id | pubmed-9734186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97341862022-12-11 Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease Yagishita, Mizuki Tsuboi, Hiroto Kuroda, Yuki Sawabe, Tomonori Kawashima, Akira Kawashima, Fumina Uematsu, Nana Sato, Ryota Nishiyama, Taihei Terasaki, Mayu Toko, Hirofumi Honda, Fumika Ohyama, Ayako Abe, Saori Kitada, Ayako Miki, Haruka Hagiwara, Shinya Kondo, Yuya Sumida, Takayuki Matsumoto, Isao Sci Rep Article Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-onset AOSD have not been reported. To clarify the clinical features and cytokine profiles of elderly-onset AOSD, we examined patients with AOSD who developed the disease between January 2006 and September 2021. We divided the patients into the young and middle-aged-onset group (aged < 65 years) and the elderly-onset group (aged ≥ 65 years) and compared the groups in terms of patient characteristics, clinical symptoms, laboratory findings including serum interleukin (IL)-6 and IL-18, treatment, and prognosis. A total of 48 patients were examined (10 in the elderly-onset group). In the elderly-onset group, atypical rash was significantly more frequent, typical rash and splenomegaly were significantly less frequent, white blood cell count and neutrophil ratio were significantly higher and serum IL-6 levels were significantly lower. Serum IL-6 showed a significantly negative correlation with age at onset. Treatment and relapse were comparable between the 2 groups, whereas infections were significantly more frequent in the elderly-onset group. The clinical features and cytokine profiles of elderly-onset AOSD might differ from those of young and middle-aged-onset AOSD. Nature Publishing Group UK 2022-12-09 /pmc/articles/PMC9734186/ /pubmed/36494453 http://dx.doi.org/10.1038/s41598-022-25514-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yagishita, Mizuki Tsuboi, Hiroto Kuroda, Yuki Sawabe, Tomonori Kawashima, Akira Kawashima, Fumina Uematsu, Nana Sato, Ryota Nishiyama, Taihei Terasaki, Mayu Toko, Hirofumi Honda, Fumika Ohyama, Ayako Abe, Saori Kitada, Ayako Miki, Haruka Hagiwara, Shinya Kondo, Yuya Sumida, Takayuki Matsumoto, Isao Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease |
title | Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease |
title_full | Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease |
title_fullStr | Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease |
title_full_unstemmed | Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease |
title_short | Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease |
title_sort | clinical features and serum cytokine profiles of elderly-onset adult-onset still’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734186/ https://www.ncbi.nlm.nih.gov/pubmed/36494453 http://dx.doi.org/10.1038/s41598-022-25514-6 |
work_keys_str_mv | AT yagishitamizuki clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT tsuboihiroto clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT kurodayuki clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT sawabetomonori clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT kawashimaakira clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT kawashimafumina clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT uematsunana clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT satoryota clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT nishiyamataihei clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT terasakimayu clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT tokohirofumi clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT hondafumika clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT ohyamaayako clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT abesaori clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT kitadaayako clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT mikiharuka clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT hagiwarashinya clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT kondoyuya clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT sumidatakayuki clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease AT matsumotoisao clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease |